Essential lessons in cardiogenic shock: Epinephrine versus norepinephrine/dobutamine

Critical Care Medicine

Volumn 39, Issue 3, 2011, Pages 583-584

  Krenn, Lisa ^a   Karth, Delle Georǵ ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

cardiogenic shock; dobutamine; epinephrine; norepinephrine

Indexed keywords

ADRENALIN; DOBUTAMINE; DOPAMINE; NORADRENALIN;

ARTERY CATHETERIZATION; CARDIOGENIC SHOCK; COMBINATION CHEMOTHERAPY; DRUG DOSE TITRATION; EDITORIAL; HEART FAILURE; HEART INDEX; HEART INFARCTION; HUMAN; HYPOTENSION; HYPOXEMIA; MEAN ARTERIAL PRESSURE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; TISSUE PERFUSION;

EID: 79952123286     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e318208e381     Document Type: Editorial

References (7)

1. Goldberg RJ, Spencer FA, Gore JM, et al: Thirtyyear trends (1975 to 2005) in the magnitude of, management of, and hospital death rates associated with cardiogenic shock in patients with acute myocardial infarction: A population- based perspective. Circulation 2009; 119: 1211-1219.
2. Sjauw KD, Engström AE, Vis MM, et al: A systematic review and meta-analysis of intraaortic balloon pump therapy in ST-elevation myocardial infarction: Should we change the guidelines? Eur Heart J 2009; 30:459-468.
3. TRIUMPH Investigators; Alexander JH, Reynolds HR, Stebbins AL, et al: Effect of tilarginine acetate in patients with acute myocardial infarction and cardiogenic shock: The TRIUMPH randomized controlled trial. JAMA 2007; 297:1657-1666. (Pubitemid 46631624)
4. De Backer D, Biston P, Devriendt J, et al: Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med 2010; 362:779-789.
5. Levy B, Perez P, Perny J, et al: Comparison of norepinephrine- dobutamine to epinephrine for hemodynamics, lactate metabolism, and organ function variables in cardiogenic shock. A prospective, randomized pilot study. Crit Care Med 2011; 39:450-455.
6. Russ MA, Prondzinsky R, Christoph A, et al: Hemodynamic improvement following levosimendan treatment in patients with acute myocardial infarction and cardiogenic shock. Crit Care Med 2007; 35:2732-2739. (Pubitemid 350175769)
7. Delle Karth G, Buberl A, Geppert A, et al: Hemodynamic effects of a continuous infusion of levosimendan in critically ill patients with cardiogenic shock requiring catecholamines. Acta Anaesthesiol Scand 2003; 47:1251-1256. (Pubitemid 37452601)